Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Winter;13(4):381-404.
doi: 10.1111/j.1527-3458.2007.00023.x.

Ginsenosides: are any of them candidates for drugs acting on the central nervous system?

Seung-Yeol Nah  1 , Dong-Hyun Kim, Hyewhon Rhim
Affiliations
Review

Ginsenosides: are any of them candidates for drugs acting on the central nervous system?

Seung-Yeol Nah et al. CNS Drug Rev. 2007 Winter.

Abstract

The last two decades have shown a marked expansion in the number of publications regarding the effects of Panax ginseng. Ginsenosides, which are unique saponins isolated from Panax ginseng, are the pharmacologically active ingredients in ginseng, responsible for its effects on the central nervous system (CNS) and the peripheral nervous system. Recent studies have shown that ginsenosides regulate various types of ion channels, such as voltage-dependent and ligand-gated ion channels, in neuronal and heterologously expressed cells. Ginsenosides inhibit voltage-dependent Ca(2+), K(+), and Na(+) channel activities in a stereospecific manner. Ginsenosides also inhibit ligand-gated ion channels such as N-methyl-d-aspartate, some subtypes of nicotinic acetylcholine, and 5-hydroxytryptamine type 3 receptors. Competition and site-directed mutagenesis experiments revealed that ginsenosides interact with ligand-binding sites or channel pore sites and inhibit open states of ion channels. This review will introduce recent findings and advances on ginsenoside-induced regulation of ion channel activities in the CNS, and will further expand the possibilities that ginsenosides may be useful and potentially therapeutic choices in the treatment of neurodegenerative disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The root of Panax ginseng C.A. Meyer (Araliaceae).
Figure 2
Figure 2
Chemical structures of the major types of ginsenosides. Numbers indicate the carbon in the glucose ring that links the two carbohydrates. Abbreviations for carbohydrates are as follows: Glc = glucopyranoside; Ara(fur) = arabinofuranose; Ara(pyr) = arabinopyranoside; and Rha = rhamnopyranoside. PD and PT stand for protopanaxadiol and protopanaxatriol ginsenosides, respectively.
Figure 3
Figure 3
Structures and metabolic pathways of ginsenoside Rb1, Re, Rg1, and Rg3 by human intestinal microflora (→, main pathway by intestinal microflora; formula image, minor pathway by intestinal microflora; ⇒, chemical transformation by steaming). Adapted from Lee et al. (2006a).
Figure 4
Figure 4
Identification of active components responsible for ginseng‐mediated inhibition on hippocampal NMDA receptors and the additive effect of 20(S)‐Rg3 and 20(S)‐Rh2 when used at submaximal concentration. In A, black dot (•) represents acute application of 100 μM NMDA in cultured rat hippocampal cells. ***P < 0.001 versus 20(S)‐Rg1 in B and indicated controls in D. **P < 0.01 versus 20(S)‐Rh2 in C. In A‐C, each ginsenoside was used at 10‐μM concentration. In D, a submaximal concentration (3 μM) was used for the additive effect. Adapted from Lee et al. (2006a).
Figure 5
Figure 5
Neuroprotective effect of ginseng total saponins (GTS) against 3‐NP in Cresyl Violet (CV), GFAP, and NADPH‐diaphorase staining in coronal rat brain sections at the level of the striatum and anterior commissure from saline (Con), 3‐NP‐treated, or GTS + 3‐NP animals. Adapted from Kim et al. (2005).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abe K, Cho SI, Kitagawa I, Nishiyama N, Saito H (1994) Differential effects of ginsenoside Rb1 and malonylginsenoside Rb1 on long‐term potentiation in the dentate gyrus of rats. Brain Res 649:7‐11. - PubMed
    1. Abebe W (2002) Herbal medication: Potential for adverse interactions with analgesic drugs. J Clin Pharmacol Therap 27:391‐401. - PubMed
    1. Akao T, Kanaoka M, Kobashi K (1998a) Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration‐measurement of compound K by enzyme immunoassay. Biol Pharm Bull 21:245‐249. - PubMed
    1. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K (1998b) Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 50:1155‐1160. - PubMed
    1. Alston TA, Mela L, Bright HJ (1977) 3‐Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci USA 74:3767‐3771. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources

-